adamantane has been researched along with Kidney Failure, Chronic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosaka, T; Kuwahara, Y; Nakamura, K; Otsuki, H; Shimomura, F; Tsukamoto, T | 1 |
| Cha, BS; Han, E; Kang, ES; Kim, BS; Kim, CS; Lee, BW; Lee, YH; Nam, JY; Park, SH | 1 |
| Gause-Nilsson, I; Haller, H; Nowicki, M; Rychlik, I; Suchower, L; Warren, ML | 1 |
| Boulton, DW; Castaneda, L; Frevert, EU; Kornhauser, DM; Li, L; Patel, CG; Tang, A; Vachharajani, NN | 1 |
| Groop, PH; Kothny, W; Lukashevich, V; Schweizer, A; Shao, Q | 1 |
| Gause-Nilsson, I; Haller, H; Nowicki, M; Rychlik, I; Schützer, KM; Suchower, L; Warren, M | 1 |
| Groop, PH; Kothny, W; Lukashevich, V; Shao, Q | 1 |
| Higashi, Y; Inoue, G; Nakata, H; Ohtomo, Y; Otsu, S; Sugitani, S; Yamaji, S | 1 |
| Deray, G; Issad, B; Izzedine, H; Launay-Vacher, V | 1 |
| Capparelli, EV; Chow, MS; Izard, M; Stevens, RC; Wills, RJ | 1 |
1 review(s) available for adamantane and Kidney Failure, Chronic
| Article | Year |
|---|---|
Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adamantane; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Dideoxynucleosides; Foscarnet; Hepatitis, Viral, Human; Herpesviridae Infections; HIV Infections; HIV Protease Inhibitors; Humans; Interferon-alpha; Kidney; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Protein Binding; Reverse Transcriptase Inhibitors; Virus Diseases | 2002 |
6 trial(s) available for adamantane and Kidney Failure, Chronic
| Article | Year |
|---|---|
Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes.
Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Kidney Failure, Chronic; Male; Middle Aged; Nitriles; Prospective Studies; Pyrazoles; Pyrrolidines; Renal Dialysis; Serum Albumin; Thiazolidines; Vildagliptin | 2014 |
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment.
Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Treatment Outcome | 2011 |
Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin.
Topics: Adamantane; Adult; Aged; Diabetes Mellitus, Type 2; Dialysis Solutions; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Half-Life; Hepatic Insufficiency; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Severity of Illness Index | 2011 |
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial.
Topics: Adamantane; Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitriles; Prospective Studies; Pyrrolidines; Treatment Outcome; Vildagliptin; Young Adult | 2011 |
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.
Topics: Adamantane; Aged; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptides; Double-Blind Method; Fasting; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Treatment Outcome | 2011 |
One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment.
Topics: Adamantane; Aged; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Nitriles; Pyrrolidines; Treatment Outcome; Vildagliptin | 2012 |
3 other study(ies) available for adamantane and Kidney Failure, Chronic
| Article | Year |
|---|---|
Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis.
Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Linagliptin; Lipids; Male; Middle Aged; Nitriles; Peritoneal Dialysis; Pyrrolidines; Renal Dialysis; Retrospective Studies; Sitagliptin Phosphate; Treatment Outcome; Vildagliptin | 2016 |
Pancreatitis with pancreatic tail swelling associated with incretin-based therapies detected radiologically in two cases of diabetic patients with end-stage renal disease.
Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucagon-Like Peptide 1; Humans; Incretins; Kidney Failure, Chronic; Liraglutide; Magnetic Resonance Imaging; Male; Nitriles; Pancreatitis; Pyrrolidines; Renal Dialysis; Tomography, X-Ray Computed; Vildagliptin | 2012 |
Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure.
Topics: Adamantane; Adult; Aged; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Rimantadine | 1988 |